Cyclacel Pharmaceuticals CYCCP

Annual report 2025
added 03-30-2026

Cyclacel Pharmaceuticals DIO Ratio 2011-2026 | CYCCP

Annual DIO Ratio Cyclacel Pharmaceuticals

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	-	-	-	-	-	-	-	-	185

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
185	185	185

DIO Ratio of other stocks in the Biotechnology industry

	Issuer	DIO Ratio	Price	% 24h	Market Cap	Country
	Acorda Therapeutics ACOR	345	-	-24.86 %	$ 820 K	USA
	Amgen AMGN	200	$ 349.36	2.75 %	$ 188 B	USA
	Amneal Pharmaceuticals AMRX	117	$ 12.67	2.82 %	$ 3.97 B	USA
	Alexion Pharmaceuticals, Inc. ALXN	512	-	-	$ 40.3 B	USA
	Arcutis Biotherapeutics ARQT	185	$ 24.45	5.07 %	$ 3.11 B	USA
	AstraZeneca PLC AZN	206	-	-	$ 96.9 B	Britain
	Midatech Pharma plc MTP	40.6	-	-18.52 %	$ 27.3 M	Britain
	Autolus Therapeutics plc AUTL	70.7	$ 1.47	8.17 %	$ 391 M	Britain
	BeiGene, Ltd. BGNE	304	-	0.49 %	$ 251 B	Cayman-islands
	Aytu BioScience AYTU	209	$ 2.72	5.84 %	$ 17.1 M	USA
	Avid Bioservices CDMO	102	-	-	$ 789 M	USA
	Институт стволовых клеток человека ISKJ	275	-	-	-	Russia
	Cerus Corporation CERS	213	$ 1.93	4.89 %	$ 368 M	USA
	Aeterna Zentaris AEZS	55.6	-	5.93 %	$ 314 M	Canada
	CTI BioPharma Corp. CTIC	38.1	-	-	$ 1.2 B	USA
	Deciphera Pharmaceuticals DCPH	2.04 K	-	-	$ 2.18 B	USA
	Dynavax Technologies Corporation DVAX	455	-	-	$ 2.02 B	USA